Abate AS Industries Fair Value
Abate AS Industries (ABATEAS) average fair value is ₹13.52 across 5 valuation models — P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, vs a current market price of ₹10.62 (+27.34%), fair value range ₹5.52–₹23.54. For live price and a broader fundamental view, visit Abate AS Industries share price chart.
Fair Value Analysis Export
ABATEAS Fair Value vs Current Price — Valuation Summary
ABATEAS average fair value, fair value range, price gap and valuation status across 5 models: P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number. Review ABATEAS P/E comparison to evaluate earnings-based valuation against sector peers.
P/E Based Valuation
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
Benjamin Graham Number
ABATEAS Fair Value Analysis — Data Sources & Coverage
Abate AS Industries financial data sources, valuation methods applied and sector benchmarks used — 2025 financial year. Also explore ABATEAS price trends to track price trends across different timeframes.
Available Data Sources: Financial statements, balance sheet data , sector comparisons.
Data Currency: Financial data is from the previous year (2025).
ABATEAS vs Healthcare Services Sector Peers — P/E, P/B & Market Cap
Abate AS Industries P/E ratio, P/B ratio and market capitalisation vs Healthcare Services sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| One Global Service Provi… | ONEGLOBAL | 17.46 | 10.73 | ₹1,126 |
| Suraksha Diagnostic | SURAKSHA | 40.64 | 5.71 | ₹1,356 |
| Fortis Healthcare | FORTIS | 73.41 | 7.64 | ₹71,815 |
| Gujarat Kidney and Super… | GKSL | 67.87 | 3.18 | ₹937 |
| Jupiter Life Line Hospit… | JLHL | 44.49 | 5.79 | ₹8,320 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.